B6.Cg-Ikbkgtm1.1Mpa/Flmg

Status

Available to order

EMMA IDEM:06968
Citation informationRRID:IMSR_EM:06968 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Ikbkgtm1.1Mpa/Flmg
Alternative nameNemo FL [B6-Ikbkgtm1.1Mpa]
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolIkbkgtm1.1Mpa
Gene/Transgene symbolIkbkg

Information from provider

ProviderManolis Pasparakis
Provider affiliationInstitut fuer Genetik, Universitaet zu Koeln
Genetic informationThis mutant line carries the conditional, floxed Nemo (Ikbkg) mutant allele (MGI symbol: Ikbkgtm1.1Mpa). Targeted ES cell clones contain the loxP flanked (floxed) Nemo allele and the FRT site-flanked neo-resistance cassette (NemoFN/Y genotype). NEMO-deficient ES cells (NemoD/Y) were generated using cre- and flp-mediated recombination.
Phenotypic informationDisruption of the X-linked gene encoding NF-kappa B essential modulator (NEMO) produces male embryonic lethality, completely blocks NF-kappa B activation by proinflammatory cytokines, and interferes with the generation and/or persistence of lymphocytes. Heterozygous female mice develop patchy skin lesions with massive granulocyte infiltration and hyperproliferation and increased apoptosis of keratinocytes. Diseased animals present severe growth retardation and early mortality. Surviving mice recover almost completely, presumably through clearing the skin of NEMO-deficient keratinocytes.
Breeding historyBred with C57BL/6J
References
  • NEMO/IKK gamma-deficient mice model incontinentia pigmenti.;Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israël A, Rajewsky K, Pasparakis M, ;2000;Molecular cell;5;981-92; 10911992
  • Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment.;Eftychi Christina, Schwarzer Robin, Vlantis Katerina, Wachsmuth Laurens, Basic Marijana, Wagle Prerana, Neurath Markus F, Becker Christoph, Bleich André, Pasparakis Manolis, ;2019;Immunity;51;367-380.e4; 31350179
Homozygous fertilenot known
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreB.S.R.C. Alexander Fleming, Vari, Greece
Animals used for archivingheterozygous C57BL/6 males

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

    • Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome / Orphanet_69088
    • X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency / Orphanet_319612
    • Hypohidrotic ectodermal dysplasia with immunodeficiency / Orphanet_98813
    • Incontinentia pigmenti / Orphanet_464
MGI phenotypes (gene matching)
  • sparse hair / MGI
  • retarded hair growth / MGI
  • enlarged spleen / MGI
  • small spleen / MGI
  • small thymus / MGI
  • tremors / MGI
  • scaly skin / MGI
  • spontaneous skin ulceration / MGI
  • thick epidermis / MGI
  • abnormal epidermis stratum basale morphology / MGI
  • abnormal epidermis suprabasal layer morphology / MGI
  • hyperkeratosis / MGI
  • decreased body weight / MGI
  • abnormal locomotor behavior / MGI
  • postnatal growth retardation / MGI
  • abnormal humoral immune response / MGI
  • reduced female fertility / MGI
  • abnormal fertility/fecundity / MGI
  • no abnormal phenotype detected / MGI
  • abnormal bone marrow cell morphology/development / MGI
  • abnormal keratinocyte morphology / MGI
  • parakeratosis / MGI
  • erythroderma / MGI
  • increased hepatocyte apoptosis / MGI
  • skin inflammation / MGI
  • decreased B cell number / MGI
  • increased apoptosis / MGI
  • absent megakaryocytes / MGI
  • decreased tumor necrosis factor secretion / MGI
  • decreased interleukin-12b secretion / MGI
  • decreased interleukin-6 secretion / MGI
  • abnormal chemokine secretion / MGI
  • decreased susceptibility to endotoxin shock / MGI
  • absent subcutaneous adipose tissue / MGI
  • abnormal dermal pigmentation / MGI
  • abnormal epidermal pigmentation / MGI
  • increased keratinocyte apoptosis / MGI
  • postnatal lethality, incomplete penetrance / MGI

Literature references

  • NEMO/IKK gamma-deficient mice model incontinentia pigmenti.;Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israël A, Rajewsky K, Pasparakis M, ;2000;Molecular cell;5;981-92; 10911992
  • Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment.;Eftychi Christina, Schwarzer Robin, Vlantis Katerina, Wachsmuth Laurens, Basic Marijana, Wagle Prerana, Neurath Markus F, Becker Christoph, Bleich André, Pasparakis Manolis, ;2019;Immunity;51;367-380.e4; 31350179

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).